These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36512307)

  • 61. Differential regulation of myeloid leukemias by the bone marrow microenvironment.
    Krause DS; Fulzele K; Catic A; Sun CC; Dombkowski D; Hurley MP; Lezeau S; Attar E; Wu JY; Lin HY; Divieti-Pajevic P; Hasserjian RP; Schipani E; Van Etten RA; Scadden DT
    Nat Med; 2013 Nov; 19(11):1513-7. PubMed ID: 24162813
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of CD25 on leukemic stem cells in BCR-ABL1
    Sadovnik I; Herrmann H; Eisenwort G; Blatt K; Hoermann G; Mueller N; Sperr WR; Valent P
    Exp Hematol; 2017 Jul; 51():17-24. PubMed ID: 28457753
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells.
    Wu L; Yu J; Chen R; Liu Y; Lou L; Wu Y; Huang L; Fan Y; Gao P; Huang M; Wu Y; Chen Y; Xu J
    Clin Cancer Res; 2015 Feb; 21(4):833-43. PubMed ID: 25501124
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kindlin-3 loss curbs chronic myeloid leukemia in mice by mobilizing leukemic stem cells from protective bone marrow niches.
    Krenn PW; Koschmieder S; Fässler R
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24326-24335. PubMed ID: 32929022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells.
    Li L; Bhatia R
    Curr Opin Hematol; 2015 Jul; 22(4):324-9. PubMed ID: 26049753
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leukemia Stem Cells in Chronic Myeloid Leukemia.
    Shan Y; DeSouza N; Qiu Q; Li S
    Adv Exp Med Biol; 2019; 1143():191-215. PubMed ID: 31338821
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
    PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
    Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
    Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.
    Schürch C; Riether C; Amrein MA; Ochsenbein AF
    J Exp Med; 2013 Mar; 210(3):605-21. PubMed ID: 23401488
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of chronic myeloid leukemia stem cells and hematopoietic stem cells by global proteomic analysis.
    Zhou S; Zhu X; Liu W; Cheng F; Zou P; You Y; Xiao Y; Guo A; Zhu X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):362-367. PubMed ID: 31767149
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
    Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P
    Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors.
    Li Q; Zhong Z; Zeng C; Meng L; Li C; Luo Y; Wang H; Li W; Wang J; Cheng F; Guo A; Liu S; Jin C; Zhu X; You Y; Zou P
    Oncotarget; 2016 Sep; 7(36):58234-58243. PubMed ID: 27533462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation.
    Jiang L; Wang H; Zhu X; Liu W; Zhou S; Geng Z; Xiao Y; Zou P; You Y; Li Q; Zhu X
    Stem Cells Dev; 2019 Nov; 28(22):1480-1485. PubMed ID: 31530245
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation.
    Liao F; Chen Y; Wu Q; Wen J; Chen X; Wang W; Xu D; Liu M
    Biochem Biophys Res Commun; 2021 Nov; 579():1-7. PubMed ID: 34571387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
    Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
    Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Critical molecular pathways in cancer stem cells of chronic myeloid leukemia.
    Chen Y; Peng C; Sullivan C; Li D; Li S
    Leukemia; 2010 Sep; 24(9):1545-54. PubMed ID: 20574455
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic myeloid leukemia stem cells.
    Houshmand M; Simonetti G; Circosta P; Gaidano V; Cignetti A; Martinelli G; Saglio G; Gale RP
    Leukemia; 2019 Jul; 33(7):1543-1556. PubMed ID: 31127148
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo.
    Sengupta A; Arnett J; Dunn S; Williams DA; Cancelas JA
    Blood; 2010 Jul; 116(1):81-4. PubMed ID: 20407032
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.
    Peng C; Chen Y; Yang Z; Zhang H; Osterby L; Rosmarin AG; Li S
    Blood; 2010 Jan; 115(3):626-35. PubMed ID: 19965668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.